IU Health Tipton Hospital is announcing a Free Prostate Cancer Screening Program scheduled for Friday, Sept. 14 from 3:30 – 5 pm. Location of the screening will be in the Cancer Service Area on the north side of the IU Health Tipton Hospital entrance 4. Participants must pre-register by calling the IU Health Tipton Hospital Cancer Service Department at 765.675.8397.
We ask that you have blood work completed before the physical exam on Sept. 14.
The PSA blood work can be done the week of Sept. 10 from 7 am – 5 pm through the outpatient lab draw area. Please enter the south lobby to register at the patient service desk of the IU Health Tipton Hospital and tell them you are there for the Prostate Cancer Screening blood draw.
Your PSA blood sample results will be available at the time of your screening appointment on Sept. 14.
Dr. Sandra McCabe, Urologist, will be providing her expertise in the physical examination portion of the screening.
Who should participate?
Prostate Cancer Screening guidelines state that all men 55-69 years old should talk with their physician about having an annual digital rectal exam (DRE) and a prostate specific antigen (PSA) blood test to help detect early prostate cancer. If you are not sure if you should participate, consult your physician.
Risk factors for prostate cancer include:
- Age: More than 75 percent of all prostate cancers are diagnosed in men over 65.
- Race: Death rates from prostate cancer for African-American men are more than twice that of Caucasian men.
- Family History: Individuals with a family history of prostate cancer experience a 2.5 fold increase in risk; 5-10 percent of prostate cancers may be inherited.
- Nutrition: There is a significant evidence indicating that a high-fat diet is linked to an increase cancer risk).
Prevention, Screening and Early Detection
Lifestyle strategies that an individual adopts may reduce prostate cancer risk. Decrease animal fats in your diet and increase consumption of vegetables, fruits, and whole grains.
The PSA test measures blood levels of protein made by the prostate. The higher the PSA level the more likely that prostate cancer is present. The PSA test alone does not provide a definitive diagnosis for or against prostate cancer. The DRE (digital rectal exam), allows the physician to feel for irregular or abnormally firm area on the prostate gland that might be cancer. The PSA and DRE are only screening tools. With any abnormal test findings the patient is advised to consult with their family physician.
To participate in the free Prostate Cancer Screening, please schedule with the IU Health Tipton Hospital Cancer Service Department at 765.675.8397.